The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function
Pharmacology Research & Perspectives · 2026-06 · 14 (3)
DOI: 10.1002/prp2.70260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 05.05.2026. Verfasst von Liam A O'Callaghan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland, Australia. Hauptthemen laut MEDLINE: Antipsychotic Agents, Aripiprazole, Urinary Bladder Neoplasms, Urinary Bladder. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Government Research Training Program Scholarship..
Abstract (Originalsprache)
Aripiprazole (ARI), an atypical antipsychotic, has demonstrated anticancer activity in several malignancies and may be a candidate for drug repurposing as an intravesical therapy for bladder cancer, particularly non‐muscle‐invasive bladder cancer (NMIBC). This study evaluated whether brief, intravesical‐like ARI exposure could induce cytotoxic effects in bladder cancer cells while preserving normal bladder structure and function. RT4 and T24 bladder cancer cells, together with non‐malignant UROtsa urothelial cells, were exposed to ARI (1–300 μM) for 30 min or 2 h, and viability was assessed at 24, 48 and 72 h. Reactive oxygen species (ROS) generation was measured in RT4 and T24 cells after 2 h pretreatment, while caspase‐3 activity and stress‐associated protein expression were examined in T24 cells. In parallel, an ex vivo porcine bladder model was used to assess the effects of luminal ARI pretreatment (300 μM, 2 h) on urothelial thickness, ATP and acetylcholine release, detrusor contractility, β‐adrenergic relaxation, and nerve‐evoked responses. ARI reduced viability in a concentration‐dependent manner in RT4, T24 and UROtsa cells, with greater cytotoxicity after 2 h pretreatment. In bladder cancer cells, ROS increased only at higher concentrations, whereas ARI increased caspase‐3 activity at lower concentrations and altered multiple stress‐related proteins in T24 cells. In porcine bladder, ARI preserved urothelial structure and mediator release, maintained detrusor and neurogenic function, and enhanced the inhibitory influence attributed to urothelium‐derived inhibitory factor (UDIF). Collectively, these findings identify ARI as a mechanistically active yet bladder‐sparing candidate for intravesical repurposing and support its further evaluation as a potential therapy for bladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland, Australia.
ORCID-Profile: Liam A O'Callaghan, Katie Powell, Russ Chess-Williams, Catherine McDermott
Förderung
- Australian Government Research Training Program Scholarship.
Zitieren
APA
O'Callaghan, L. A., Powell, K., Chess-Williams, R., & McDermott, C. (2026). The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function. Pharmacology Research & Perspectives, 14(3). https://doi.org/10.1002/prp2.70260
Vancouver
O'Callaghan LA, Powell K, Chess-Williams R, McDermott C. The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function. Pharmacology Research & Perspectives. 2026;14(3). doi:10.1002/prp2.70260
BibTeX
@article{OCallaghan2026,
author = {O'Callaghan, Liam A and Powell, Katie and Chess-Williams, Russ and McDermott, Catherine},
title = {The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/prp2.70260}
}
EUVIMED